Clinical Trials Logo
  1. Home
  2. Alzheimer Disease
  3. NCT04897464
  4. Details
NCT04897464 Clinical Trial

Validation Study of a New Digital Treatment Test

Alzheimer Disease Clinical Trial

Official title:
Validation Study of a New Digital Treatment Test Based on Interactive Video Games for Alzheimer's Disease

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04897464
Other study ID # BT-AD-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2021
Est. completion date May 31, 2022

Study information
Verified date May 2021
Source Braingaze
Contact Hans Super
Phone 0034931696572
Email hans@braingaze.eu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Oculomotor behavior and cognitive processing of visual information are intimately connected. AD patients show ocular movement problems. Oculomotor deficits are broad consisting mainly of different saccade metrics, altered pupil responses. and smaller and irregular eye vergence movements. Here we test an interactive eye-tracking game to improve eye motion control and thereby training cognitive behavior

Recruitment information / eligibility
Status Recruiting
Enrollment 60
Est. completion date May 31, 2022
Est. primary completion date March 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 85 Years
Eligibility Inclusion Criteria: 1) Clinical diagnosis of MCI or AD Exclusion Criteria: 1. Severe cognitive deterioration 2. History of neurological disease with clinically relevant impact on cognition 3. Severe psychiatric disorder 4. Incidental structural brain findings with impact on cognitive impairment 5. Presence of relevant visual problems

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• BGaze therapy Alzheimer
BGaze Therapy is an interactive eye tracking game

Locations
Country Name City State
Spain Braingaze Mataró Barcelona

Sponsors (1)
Lead Sponsor Collaborator
Braingaze

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary MoCA Measure changes in MoCA immediately after the intervention
Primary MMSE Measure changes in MMSE immediately after the intervention
Secondary CANTAB Measure changes in CANTAB tests immediately after the intervention
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A